Dexcom stock received a raised price objective and rating restatement from analysts, accompanied by SEC filings.

The entities involved

• Dexcom →

  company that develops, manufactures and distributes continuous glucose monitoring systems

  • Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18
  • Oura announces partnerships with Dexcom and Resmed for health feature integration, while noting that regulatory uncertainty affects its product scope.Wed 08:52
• Citigroup →

  American investment bank and financial services corporation

  • Citigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Mon 11:05
  • Citigroup and Jefferies Financial Group downgraded the stock rating for Yara International on June 26, 2026.Mon 10:14
• Royal Bank of Canada →

  financial institution in Canada

  • Royal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Mon 16:02
  • PrairieSky Royalty Ltd. operates in the Western Canadian Sedimentary Basin and is currently receiving research ratings from Royal Bank of Canada (RBC).Mon 09:02

Related events

• Norges Bank bought a new stake in Dexcom and Geode Capital Management increased its stake on August 30, 2026.Aug 30
• Mizuho and Royal Bank of Canada raised price targets and gave outperform ratings for GE Vernova shares.Aug 30
• Truist Financial and Citigroup provided buy ratings and price objectives for Crown stock.Aug 19
• Morgan Stanley and Royal Bank of Canada adjusted ratings and price targets for TransDigm Group Incorporated stock.Sep 19
• RBC and Citigroup boosted price objectives on Lockheed Martin shares, with MarketBeat aggregating the analyst ratings.Sep 11